Keyphrases
Resection
100%
Low Expression
100%
Squamous Cell Carcinoma (SqCC)
100%
Lung Adenocarcinoma
100%
Reversion-inducing Cysteine-rich Protein with Kazal Motifs
100%
Adenocarcinoma
75%
MMP14
75%
Tumor
50%
Matrix metalloproteinase-2 (MMP-2)
50%
Matrix metalloproteinase-9 (MMP-9)
50%
Tissue Sampling
50%
Quantitative PCR
25%
Non-small Cell Lung Cancer (NSCLC)
25%
Lung Tissue
25%
Univariate Analysis
25%
Expression Level
25%
Tumor Angiogenesis
25%
Patient Prognosis
25%
Adenocarcinoma Cells
25%
Prognostic Factors
25%
Prognostic Value
25%
Stage IB
25%
Matrix Metalloproteinase Inhibitors
25%
Lung Cancer Tissue
25%
Healthy Lung
25%
Cox Regression Analysis
25%
Tumor Invasion
25%
MT1-MMP
25%
Curative Resection
25%
Primary Lung Cancer
25%
Relapse-free Survival
25%
Tumor Metastasis
25%
Resectable Lung Cancer
25%
Inhibit Tumor
25%
Quantitative Real-time
25%
Medicine and Dentistry
Surgery
100%
Adenocarcinoma
100%
Cysteine
100%
Kazal Motif
100%
Revertant
100%
Squamous Cell Carcinoma
57%
Matrix Metalloproteinase 14
57%
Neoplasm
28%
Non Small Cell Lung Cancer
28%
Gelatinase A
28%
Gelatinase B
28%
Lung Cancer
14%
Proportional Hazards Model
14%
Quantitative Reverse Transcription Polymerase Chain Reaction
14%
Metastatic Carcinoma
14%
Secretion (Process)
14%
Univariate Analysis
14%
Cancer Tissue
14%
Recurrence Free Survival
14%
Matrix Metalloproteinase Inhibitor
14%
Tumor Angiogenesis
14%
Biochemistry, Genetics and Molecular Biology
Revertant
100%
Cysteine
100%
RECK
100%
Kazal Motif
100%
Matrix Metalloproteinase
27%
Gelatinase B
18%
MMP9
18%
Gelatinase A
18%
MMP2
18%
Angiogenesis
9%
Secretion (Process)
9%
Quantitative Reverse Transcription Polymerase Chain Reaction
9%
Recurrence Free Survival
9%
Membrane-Type Matrix Metalloproteinase-1
9%
Matrix Metalloproteinase Inhibitor
9%